Screening, Skin Cancer, Telemedicine
Conditions
Keywords
Skin cancer, Teledermatology, Screening, Store-and-forward
Brief summary
The purpose of this study is to determine the diagnostic and management concordance of face-to-face dermatologist versus a store-and-forward teledermatologist at a skin cancer screening event. The investigators' hypotheses include the following: 1. Compared to in-person assessment, store-and-forward teledermatology assessment will result in adequate diagnostic concordance. 2. Compared to in-person assessment, store-and-forward teledermatology results in adequate management concordance. 3. The sensitivity and specificity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant will be similar to that of in-person evaluation.
Interventions
OTHERIn-person dermatology evaluation
Every patient will be evaluated by an in person dermatologist present at the screening.
OTHERStore-and-forward teledermatology evaluation
Every patient will be evaluated online via a store and forward teledermatology modality.
Sponsors
University of California, Davis
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* 18 years of age or older at time of consent, may be male or female. * Able to provide a brief medical history and have/allow an examination of their skin including photographs. * Capable of giving informed consent. * Will be able to receive notification of follow-up recommendations
Exclusion criteria
* Patients who will not provide informed consent * Patient who are unable to fulfill tasks of this study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Aggregated diagnostic concordance | At the time of dermatologist evaluation (Day 1) | Aggregated diagnostic concordance which is defined as the agreement of the in-person dermatologist's principle diagnosis with the teledermatologist's primary diagnosis or any of the differential diagnoses. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Primary diagnostic concordance | At the time of dermatologist evaluation (Day 1) | Diagnostic concordance between the in-person dermatologist and the teledermatologist for their primary diagnosis. |
| Categorical diagnostic concordance | At the time of dermatologist evaluation (Day 1) | Diagnostic concordance between the in-person dermatologist and teledermatologist based on standard clinical diagnostic categories for each lesion. |
| Management concordance | At the time of dermatologist evaluation (Day 1) | The concordance between the in-person dermatologist and teledermatologist for the chosen management plan for each lesion. |
| Sensitivity | At the time of dermatologist evaluation (Day 1) | The sensitivity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant. |
| Specificity | At the time of dermatologist evaluation (Day 1) | The specificity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant. |
Countries
United States
Outcome results
None listed